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about AIM
contents
AIM consists of:
! Over 300 AIM Fellows and Scholars – all leading academics in their fields…
! Working in cooperation with leading international academics and specialists
as well as UK policymakers and business leaders…
! Undertaking a wide range of collaborative research projects on management…
! Disseminating ideas and shared learning through publications, reports,
workshops and events…
! Fostering new ways of working more effectively with managers and policymakers…
! To enhance UK competitiveness and productivity.
AIM’s Objectives
Our mission is to significantly increase the contribution of and future capacity
for world class UK management research.
Our more specific objectives are to:
! Conduct research that will identify actions to enhance the UK’s international
competitiveness
! Raise the quality and international standing of UK research on management
! Expand the size and capacity of the active UK research base on management
! Engage with practitioners and other users of research within and beyond the
UK as co-producers of knowledge about management
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AIM research themes
Current AIM research projects focus on:
UK productivity and performance for the 21st century.
How can UK policymakers evaluate and address concerns surrounding the UK’s
performance in relation to other countries?
National productivity has been the concern of economists, government policymakers,
and corporate decision-makers for some time. Further research by scholars from a
range of disciplines is bringing new voices to the debates about how the productivity
gap can be measured, and what the UK can do to improve the effectiveness of UK
industry and its supporting public services.
Sustaining innovation to achieve competitive advantage
and high quality public services.
How can UK managers capture the benefits of innovation while meeting other
demands of a competitive and social environment?
Innovation is a key source of competitive advantage and public value through new
strategies, products, services and organisational processes. The UK has outstanding
exemplars of innovative private and public sector organisations and is investing
significantly in its science and skills base to underpin future innovative capacity.
Adapting promising practices to enhance performance
across varied organisational contexts.
How can UK managers disseminate their experience whilst learning from others?
Improved management practices are identified as important for enhancing
productivity and performance. The main focus is on how evidence behind good or
promising practices can be systematically assessed, creatively adapted, successfully
implemented and knowledge diffused to other organisations that will benefit.
4
5executive summary
Without radical
innovation it
seems unlikely
that we can
sustain the kind
of healthcare
which we
associate
with highly
developed
societies.
Healthcare systems in the early 21st century face a crisis. Rising demand and
expectations are increasingly out of step with the funding models available. Without
radical innovation it seems unlikely that we can sustain the kind of healthcare which
we associate with highly developed societies.
The healthcare sector has always been characterised by innovation – in treatments
and drugs, in hospital and care systems, in primary and acute care pathways and
in chronic disease management. But arguably the system suffers from the problem
facing all kinds of organisations – a recognition that, despite huge commitment and
investment in generating innovation, ‘not all the smart guys work for us’. The ideas
behind ‘open collective innovation’ essentially involve finding ways to spread the
knowledge net much more widely, bringing into the innovation process a wider range
of players and mobilising their experience and creativity in the search for novel and
sustainable solutions.
One key direction in which healthcare innovation can open up lies in harnessing the
innovation potential of patients and their carers. We already know of many examples
where patients have been a key source of innovation; in today’s environment the
challenge is to find ways of scaling this to help deal with the innovation crisis.
One powerful route is opened up via interactive web-based platforms which build and
mobilise communities with common interests. This report discusses the potential of
Web 2.0 interactive platforms and provides examples of several which appear to offer
considerable additional traction in developing innovative solutions to the healthcare
issues faced by such patients.
6In many countries around the world, healthcare costs are soaring at an unsustainable
rate which considerably exceeds GDP growth. For several major countries, such as
the UK, France, and Germany, healthcare costs consume around 10% of GDP and are
increasing at roughly twice the rate of economic growth (see figure 1). This is partially
due to a demographic change where populations of developed economies are ageing
and those of developing economies are growing. Western countries, in particular,
are witnessing diminishing birth rates and increasing life expectancy.
Rapidly rising costs might be acceptable if they were accompanied by gains in
efficiency or quality of care. However, some countries spend less on healthcare
than others while at the same time their people live longer. In the UK, for example,
healthcare expenditure per capita is significantly less than that in Denmark, yet people
are expected, on average, to live 1.5 year longer (see figure 2). Other figures from
a US publication estimate that $700 billion out of a total $2.5 trillion US healthcare
budget is considered wasted due to inefficiencies, overtreatment, and error. In other
words, higher spending does not inevitably lead to better outcomes for patients.
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Figure 1: Healthcare costs are rising globally at unsustainable rates
Figure 2: Higher costs are not buying better healthcare – 2009 healthcare spend
per capita versus life expectancy for selected countries
Note: Index on basis of local currency
Source: OECD Health Data 2011
1 Life expectancy at birth (years) 2009
2 Per capita total expenditure on health at average exchange rate (US$) 2009
Source: CIA World Factbook; World Health Organization Data Repository
8players in the healthcare system
The healthcare sector as a whole, which represents about $5.5 trillion or 8% of
the global economy, is certainly one of the industries made up of a very diverse set
of players representing a wide range of interests. In fact, five major groups can
be distinguished here (see figure 3):
! Regulators, e.g., ministry of health, national or regional committees who set
regulatory guidelines
! Providers, e.g., doctors, nurses, other health professionals and medical experts
who provide care in hospitals, doctor’s surgeries, nursing homes, and others
! Payers, e.g., statutory health insurance, private health insurance, and government
agencies
! Suppliers, e.g., scientific institutions, pharmaceutical and medical technology
companies, who develop new products and treatments and heavily invest in
research and development; pharmacies and wholesalers, who mostly do resale
! The patients as beneficiaries of care and, increasingly, as a knowledge base for
their disorders
Figure 3: Healthcare landscape is traditionally dominated by five types of players
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Purely quantitatively, in terms of number of people involved, patients are the largest
group. They have gained enormous experience, either directly through their own
health records, or indirectly through the suffering of relatives or friends. As a result
many patients have developed ideas of how to make the process of care more
efficient, of how to improve a medical device, or how to test new ways of treatments
in the case of patients with life-changing conditions. Nevertheless, health suppliers
and other stakeholders have been reluctant to absorb the patient’s ideas into their
processes. This is surprising, as from an innovation perspective, patients can serve
as valuable knowledge resources.
In the case of the UK National Health Service (NHS) a combination of complex drivers
is creating the conditions that will cause the current systems to fail. Increasing life
expectancy means more people will require support for longer – and many will suffer
from chronic diseases which are age-related, such as diabetes and stroke, which are
particularly expensive to treat.
9The NHS is
already a huge
and complex
organisation
– the largest
employer in
Europe with
the biggest
purchasing
budget.
Other lifestyle-linked problems such as growing obesity levels put further pressure on
a system which already consumes around 10% of GDP – yet this burden will have to
be borne by a shrinking taxpayer base as the population distribution ages. Expectations
have risen since the inception of the NHS in 1947, but continuing to deliver a broad-
based package of care, free at the point of delivery, and without incurring crippling
financial costs, is likely to become impossible in the years to come. The problem is
not amenable to simple single point solutions like a new drug or therapy – instead
it requires system-level intervention involving patients, carers, drugs and other
treatment regimes across a broad therapeutic range, healthcare funding, etc.
The NHS is already a huge and complex organisation – the largest employer in Europe
with the biggest purchasing budget. There is a complicated web of actors within the
system – clinicians, managers, associated service providers, etc. – and it interacts
with a very wide range of stakeholders – patients, carers, relatives, medical suppliers,
funding agencies, local and national government, for example.
Innovation in this system involves both the diffusion of improvement innovations and also
radical new treatments and approaches, such as new equipment or surgical techniques.
But it is likely that the fundamental shifts and rising complexity facing the NHS will mean
that there is increasing pressure towards completely different models which require
reframing, and the emergence/co-evolution of radically different alternatives.
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The need to manage such change is widely recognised – the NHS itself has recently
concluded a 10 year reform programme – and there is growing recognition that
existing perspectives, methods and approaches (and the underlying theories that
drive them) cannot be relied upon to deliver the required change in the time and on
the scale required. A key theme in the exploration of such radical alternatives is the
need to incorporate new elements and perspectives and in particular to find ways
to engage users much more actively.
One approach, advocated in the 2002 Wanless report, placed considerable weight
on the role of the patient as a key architect in developing healthcare systems for the
future. It emphasises that better access to information can help patients to be fully
involved in decisions, not just about treatments, but also about the prevention and
management of illness. With user involvement gaining more importance, the role
of the patient is moving beyond an ‘informed consent’ to an ‘informed choice’.
As a report by Leadbeater, 2004, put it, “current approaches to public service
reform are reaching their limits… a wide range of prominent issues, including the
environment, crime, and public health concerns such as smoking and obesity, cannot
be adequately addressed by traditional services. Effective responses must encourage
new norms of behaviour within society, developing approaches in which those who
use services become involved in their design and delivery… we need a radical
transformation and a new approach: co-created services”.
Co-created services of this kind require mobilisation of knowledge and resources
which are distributed across communities and an active engagement of members
of those communities – rather than central and unilateral supply driven solutions.
This raises the issue of user-led innovation again. Co-design also helps deal with
the customisation argument – rather than trying to design one size fits all, work
with diverse users allows configurations which bring their particular set of needs
and wishes into the equation.
This mirrors the wider moves towards what Eric von Hippel, Professor of
Technological Innovation in the MIT Sloan School of Management, calls the
democratisation of innovation and implies much higher levels of user-engagement in
design and development of customised solutions matched to local and specific needs,
rather than a generic one-size-fits-all approach. At the same time, such alternatives
need to reflect the economic challenges of delivering high quality care in such specific
configurations – there is a risk that innovations will revert to the traditional cost/quality
trade-offs common to manufacturing operations management during the last century.
Searching for such radical solutions which engage users and which also deliver
workable options requires the use of new tools and techniques and a number
of experiments are underway which draw on design approaches.
imperative for open innovation
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Related to the increasing need for innovation in healthcare, there is a paradigm shift
in managing innovation. Often referred to as open innovation, this approach is about
achieving and sustaining a higher degree of innovation by opening up the traditionally
closed innovation process. It suggests that the process of product and service
development should better integrate and leverage external knowledge resources
provided by a wide range of external actors, such as customers and users. These
external actors enable the innovating organisation to learn more easily about their
needs, and to benefit straight away from their solution proposals for specific
problems they might already have in mind.
Unlike traditional methods of market research, which are typically applied before the
innovation process starts, open innovation allows external actors to be involved all
the way along the entire innovation process. Customer integration is feasible during
earlier stages of the process, such as idea generation and conceptualisation, as well
as later stages, like development or prototyping.
Clearly there is considerable potential in approaches which mobilise a wider
community, including patients and carers as a part of the ‘innovation front end’
in healthcare.
Related to the
increasing need
for innovation
in healthcare,
there is a
paradigm shift
in managing
innovation.
One powerful set of tools, already widely used in industry to enable open innovation,
are those which mobilise the enormous reach of the internet to create platforms on
which shared exploration of healthcare challenges can take place involving a wide
community. The emergence of interactive capabilities in the online space can be an
effective source of jointly constructed and shared knowledge through the participation
of patients, caregivers, health professionals, researchers, and others.
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Patient engagement in service design at Luton and Dunstable Hospital
Improvement collaboratives – where members of multidisciplinary health teams
work together both within and across organisations with a commitment to improving
services – have emerged as a popular method for change within healthcare. Their
impact includes significantly reducing waiting times and streamlining services.
Typically such approaches – deployed for example in improving outpatient care
– involve a range of staff including, nurses, clinic clerks, diagnostic services staff,
doctors, secretaries and managers. Whilst they try to collect and integrate user’s
views into the redesign of services, there are fewer examples where patients
and staff are jointly and equally involved in a co-design process.
Work at Luton and Dunstable hospital involves using design methods to create a
user-led solution to the challenge of improving patient care amongst neck and head
cancer sufferers.The approach involves patients and carers telling stories about their
experience of the service; these stories provide insights which enable the team of
co-designers to think about designing experiences rather than designing services.
Importantly the role of designer includes all of those involved in the collaborative process:
patients, staff, researchers, improvement leaders as well as design professionals.
By identifying the main areas or ‘touch points’ where people come into contact with
the solution, where their experience is shaped, it tries to identify where the desired
emotional and sensory connection needs to be established. Then, by working with
people in the front line – doctors, nurses, and hospital administrative staff – the
team can begin to design experiences rather than just systems or processes.
In the Luton and Dunstable Hospital such co-design has led to changes – for example
patients and carers have changed project documentation so that it better reflects
their needs, and clinic staff and patients have worked together to redesign the flow
of outpatients in the consulting room. Various methodologies were used to encourage
patient involvement in the process, including patient interviews, log books and film-
making. This enabled patients to show their experience of the service through their
own lens, and bring their story to life for others.
The initial co-design group identified 38 different actions to be taken, all based on user
experience. Great care is taken to explicitly link the experience to the action by using
actual narrative as expressed by patients or carers; this helps to retain the ‘story’
that has influenced the change. Many of the changes requested by patients required
relatively tiny actions, for example, staff moved the weighing scales out of sight of
the waiting room; they hadn’t noticed how embarrassed patients were to be weighed
in front of everyone. However, the impact of such a small gesture is potentially huge
when people’s experiences of the service are mapped. Other actions, such as changing
the way the clinic space is used, have required more thought or organisation, yet
many of these have been achieved quickly and inexpensively while still resulting in
a significant difference to the patient experience. Based on: Bessant & Maher (2009)
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The Bolton diabetes care prototype
One of the major health issues identified by the Wanless report in 2002 is the rising
challenge of chronic disease. Around 12 million (approximately one in five Britons)
suffers from a chronic disease. These numbers are likely to rise if factors influencing
chronic conditions, such as diet, lifestyles, and smoking, are not addressed as the
population ages. The incidence of diabetes for example, closely related to obesity,
has risen to 1.8 million people in just eight years, costing the NHS £10 million a day.
It represents a complex problem but also one in which a patient-driven approach might
offer significant new opportunities. For example, the average person with diabetes
spends about three hours a year with doctors, checking prescriptions and general
health – but they spend thousands of hours a year self-managing their condition.
As the Wanless report argues, the future of healthcare in an era of chronic disease
would turn on the ‘full engagement’ of people in their own healthcare. Whilst
hospitals play a key role, there is scope for much higher levels of engagement across
the user community. One experiment in this direction has been work towards co-
creation/co-evolution of new diabetes services within the Bolton area of north-west
England. At present an estimated 10,000 residents suffer from diabetes (almost one
individual in every ten households) in the area. This absorbs 5% of NHS resources
locally, and 10% of hospital patient resources, a pattern that is similar to that
nationally, exemplifying the challenges of chronic disease management. In response,
Bolton has already developed an impressive track record of ‘traditional’ innovation
solutions to the problem but progress has been largely inspired by the professional
managers and clinicians rather than diabetics themselves.
The RED project was a prototype which looked at the ways in which the interface
between people with diabetes and a range of required services could be made
seamless and at ways in which diabetics might co-support each other. The core idea
was that a co-created service would entail both participation and change on the part
of the diabetics themselves and the professionals currently engaged in delivering
services. This would have continuing implications for the organisation of the service
itself and for bottlenecks within it. In Bolton for example there is a two year waiting
list for orthopaedic shoe fittings (cost £100) which can save the need for amputations
(cost between £30,000 and £40,000). Such bottlenecks are far from unique to
Bolton or to diabetes management and reinforce the need to maintain prevention
as a founding principle in the approach to co-creating services.
Having advertised the project in GP surgeries in the area, the team found a group of
20 willing participants, all diabetes sufferers ready to share their experiences of living
with the condition. The first stage of the project involved focusing on the group’s
individual lives not just their disease, and building up an in-depth understanding of the
real issues that affect sufferers’ ability (or inability) to manage their diabetes effectively
from day-to-day. Over time, common patterns began to emerge within the group,
and it became possible to identify three profile categories based on how individuals
approach and manage their condition; ‘knowing struggler’, ‘determinedly naïve’ and
‘able knower’. Further work with these different groups and their carers involved
extensive prototyping and experimentation. Based on: Bessant & Maher (2009)
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web 2.0 in healthcare
The term Web 2.0 was initially introduced following the O’Reilly Media Web 2.0
conference in 2004. It summarises the changes that had happened on the internet and
the way its users deal with it. A set of economic, social, and technological trends led
to the next generation internet which is characterised by user participation, openness,
and network effects. Compared to Web 1.0, the so-called first generation of the
internet, the difference with Web 2.0 is foremost about user interaction. While
Web 1.0 was mainly about unidirectional information retrieval, users can create and
add information and content to the Web. For that reason the amount of user-generated
content has increased enormously. Since then online communities, in which users
can participate and share content, have become very popular.
While other big industries have adopted the advantages of the information technology
age since the 1980s, the healthcare sector has been quite slow to do the same,
especially in support of coordination and cooperation between institutions. Now the
influence of technological advance on healthcare is likely to increase further.This recent
trend has also had an impact on healthcare related online offers which are then described
as health 2.0 or medicine 2.0. Both terms cannot be separated distinctly, and are
sometimes used synonymously.They are subsumed in the broader term e-health
which was first introduced in 2000 in the context of telemedicine. According to the
existing definitions of health 2.0, there are seven leading themes:
1 Web 2.0 as the underlying technology for communication and information sharing
2 Increased participation or empowerment of patients or consumers of healthcare
3 Apart from patients only, increased participation or empowerment of health
professionals or other stakeholders, e.g. payers, providers, researchers
4 Emergence of online communities and social networking in health 2.0
5 Improving collaboration between patients and health professionals
6 Stronger focus on health information and content, one that is patient-driven
or user-generated
7 Positive impact or change on the healthcare system in terms of higher quality
and efficiency in healthcare
Recent studies show that the number of internet users worldwide that go online for
health-related purposes is growing significantly. Over the past few years, many online
platforms for patients have arisen to give information about disorders and to facilitate
networking with like-minded sufferers. These websites help patients to better
understand and manage their individual health status. The implemented functionality
ranges from simple information distribution and general health advice to highly active
patient communities specialising in rare conditions. Also, some of the platforms
integrate elements of open innovation – if it is bringing people together who have
not exchanged ideas and knowledge before, or solution-oriented discussions around
users’ problems.
It is claimed that the combination of innovation and health 2.0 is a powerful
and radical way to change medical practice and the current role of patients.
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Groups of Innovators
With the recent shift towards open innovation, innovation processes have to integrate
three distinct types of innovators: core inside innovators; peripheral inside innovators;
and outside innovators. Traditional research and development (R&D) departments,
classified as core inside innovators, have a central role filling the innovation pipeline
with promising ideas.
Employees from other departments than R&D are named peripheral inside innovators.
This group is not directly responsible for innovation. Through their daily job, though,
they gain relevant experience and knowledge that can be a valuable contribution
to the innovation process.
Beyond the organisation’s boundaries, outside innovators represent all external players
like customers, users, retailers, suppliers, and competitors. When they participate in the
innovation process, their heterogeneous backgrounds and the outside-in perspective
can create enriching contributions.This typology of innovators can be applied to value-
creating supply networks of multiple stakeholders with differentiating roles – as is the
case in the healthcare domain.
Hence, one way to classify health 2.0 platforms is to look at the groups of innovators
involved in healthcare. The patient stands at the end of a complex industry whose
leading rationale is to improve healthcare. More strikingly, the patient is the source
where health issues originate – or at least where they first appear. The patient’s
health status and diseases are the subject matter of the players involved in
healthcare. In short, the patient is both actuator and receiver of all health-related
efforts. Accordingly, the differentiation of the three types of innovators introduced
before needs to be adjusted and led by a patient-centric perspective.
From the perspective of a patient, there are numerous relationships to problem
solvers who can deal with the patient’s health problems. In the first place, it is
the patient’s relationship to any sort of care providers, such as a dedicated general
practitioner who typically has the best overview of the patient’s health status. In the
course of medical treatment, the GP might send the patient to medical specialists
for further examination. In addition to the GP, the patient could consult other health
professionals and medical experts on a one-to-one basis, ranging from technical
encyclopaedia to health counsellors from industry partners. We consider the different
instances of medical experts described here as core inside innovators – they all share
a direct and very close relationship to the patient while acting as qualified problem
solvers for the patient’s health issues.
As a consequence of health 2.0, the traditional one-to-one relationship between
doctor and patient is supplemented by a number of new relationships with like-
minded people. Here, one major group consists of fellow patients who suffer from
a similar disease pattern, and also their caregivers and family relatives who suffer
indirectly. They all have acquired relevant experience and knowledge in the same
field. As fellow sufferers are less familiar with the patient’s detailed situation than
the supervising GP but still can share relevant experience, this group could be
considered as peripheral inside innovators from a patient-oriented perspective.
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Other stakeholders who do not directly share disease experience with the patient
make up a third type of innovator. They can contribute specific technical knowledge
in order to solve, or at least facilitate dealing with, the patient’s health problem.
These could come from the side of suppliers, payers, and regulators. Typical examples
are industry partners like medical device manufacturers or service businesses
specialised in a particular aspect of medical care. According to the previous logic
of patient-centric perspective, we consider this group outside innovators.
To conclude, one approach to classify health 2.0 platforms is about patient-related
innovator groups consisting of three clusters: medical expert-to-patient relationships;
patient-to-patient relationships, and other stakeholder-to-patient relationships.
It is conceived as a shell model, which means that, for example, patient-to-patient
relationships are consecutively based on expert-to-patient relationships (see figure 4).
Figure 4: Classical relationship patient-doctor enhanced by relationships
created in virtual communities
Patient Patient
e.g. classical
relationship
Patient – Doctor
e.g. Patient
– Industry
to facilitate
clinical trials
Collective
interaction in virtual
communities
Number
of people
Patient Stakeholder
Patient Expert
Degree of Innovation
An important aspect of innovation is the degree of novelty involved. Obviously,
upgrading minor details of a product like improving medical care through new ways
of servicing is not the same as finding a formula fighting an HIV infection or a rare
disease. There is a continuum extending from minor, incremental improvements to
discontinuous, radical changes. The latter can be far-reaching, potentially changing the
basis of society, as the impact of today’s information and communication technologies
has shown in recent years, for example.
Incremental innovations are more widely seen in practice than ‘new to the world’
products. The cumulative gains in efficiency which come with incremental changes
are often larger over time than gains from occasional radical innovations. Unlike
incremental improvements, radical innovations change the rules of the game and
challenge the boundary conditions (technology, markets, social, regulatory, etc.),
they enable a new opportunity space for innovation. Radical innovations account
for only 6% to 10% of all innovation projects.
Radical
innovations
account
for only 6%
to 10% of all
innovation
projects.
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These differences are important when it comes to managing the innovation process.
Certainly, day-to-day, incremental changes need a different management approach
than those applied occasionally to control radical step changes in products, services
or processes. Yet it is important to note that it is the perceived degree of novelty
which matters.
Another way to classify health 2.0 platforms is by the outcome focus of health 2.0
platforms.The online platforms currently available in the health 2.0 space differ widely in
their mission statements. When we look at them from a dedicated innovation standpoint,
we narrow the focus down to the impact such a site can have on the emergence of
innovation. More specifically, due to the relative novelty of a number of sites, the focus
is on the anticipated outcome. Classification may be done through declared intention
by platform operators as well as assessment by innovation researchers.
On the one hand, there are online sites which do not, or at least not to a recognisable
extent, have a dedicated innovation focus but which still operate successfully in
the health segment. These are mostly sites characterised by unilateral information
dissemination, e.g., on general health advice, or sites providing basic functionality on
managing personal health records electronically (without connecting to a community).
1 http://genomics.xprize.org
On the other hand, online platforms with a clear innovation focus can be classified by
the degree of change an innovation is likely to cause.The change can be incremental or
radical. For example, a typical online self-help group with forum certainly has the potential
to create incremental innovations. In contrast to that, rewarded innovation contests
like the Archon Genomics X Prize1, are more likely to produce radical innovations.
Finally, another approach to classify health 2.0 platforms relates to the outcome focus
of health 2.0 platforms. It consists of three clusters: focus on information; focus on
incremental innovation; and focus on radical innovation.
…day-to-day,
incremental
changes need
a different
management
approach than
those applied
occasionally…
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exemplary health 2.0 cases
CureTogether
CureTogether 2 is a type of social network which attempts to solve medical challenges
through the collective knowledge or experiences of the patient crowd. The site which
started in 2008, and counts over 22,000 patient members (as of October 2011), is
organised around support groups on specific conditions. The most popular support
groups with more than 5000 members deal with anxiety, depression, and back pain.
Smaller groups discuss topics such as heartburn, adrenal fatigue, and stomach pain.
In total there are over 500 medical conditions supported.
It is different to other general support disease communities in that there is not a lot
of social, story-sharing on the site. The focus is on anonymous patient profiles and
their experiences shared as data. Data is recorded through a structured questionnaire
that is available for every supported condition. Survey questions ask for patients’
experience on symptoms, treatments, side effects, and causes. The list of symptoms
or treatments can be supplemented by user’s input if the desired answer is not in the
list. Accordingly, the more patients participate, the more comprehensive the survey
becomes. Despite the lack of some ‘social networking’ elements such as discussion
boards, patients are able to privately and anonymously contact others who suffer
the same combination of conditions that they do, and exchange experiences.
2www.curetogether.com
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psychological
treatments
they have
undergone.
Analysis of the given data is anonymously provided straight on the platform.
Users can instantly compare their individual disease experience with data shared
by others. First, survey results of all respondents are presented in an aggregated
form, detailing absolute and relative numbers about, for example, the most common
symptoms and most popular treatments. Second, a two-dimensional matrix compares
treatments by popularity and effectiveness.
Equipped with these preliminary results at hand,CureTogether strives to provide the
patients’ data for research purposes. There are active partnerships with universities
and research organisations which have led to a series of publications and on-going
studies. Research findings have to be seen in the context of its limitations as it is
based on patient-reported data only and there may be a potential bias in patient self-
selection and recall. Yet it serves as a stimulus for discussion and further research.
CureTogether illustrates how the engagement of patients is changing. The website
is not only empowering patients to share experiences with each other, but to develop
their own evidence base and to generate new knowledge from it.
DailyStrength
DailyStrength3 is a social networking site that focuses on the development of patient
communities. The platform, founded in 2006, has approximately 400,000 registered
users (as of October 2011), and addresses people with a wide variety of medical,
psychological and life conditions ranging from general health to chronic disorders.
Its users are mainly health seekers, patients, or members of self-help groups,
but also include care givers, supporters and medical professionals.
The main function of DailyStrength lies in its 500 plus communities which focus on
conditions such as autism, infertility, smoking addiction, and several types of cancer.
Discussion boards help users to talk about their struggles and treatments, to exchange
knowledge, and to give and receive emotional support from people facing the
same circumstances.
Outside of the discussion boards, users are able to ask questions to find quick answers
and straight-forward solutions through other experienced users. Another highlight
is that users are encouraged to write a journal about medical and psychological
treatments they have undergone. That information is then aggregated by condition
and treatment and it becomes easy to see what a large number of people have done
in response to a condition.
DailyStrength relies on a board of medical advisors who are active members of the
team. They contribute to feature design and community creation and also participate
as community members or blog editors in their respective areas of expertise.
3www.dailystrength.org
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Gemeinsam für die Seltenen
GemeinsamSelten4 allows users to initiate and participate in finding ideas and solutions
that help sufferers of rare diseases. The site, which has added over 1000 members
since its launch in March 2011 and addresses a German-speaking community, has
three main functional components: an innovation initiative based on a series of
contest-like challenges; a social network; and a marketplace for exchanging problems
and ideas.
The platform strives to collect the problems of rare disease patients and, thereby,
increase public awareness. The aim of the site is to develop innovative solutions for
the patients’ reported problems through innovation contests. Across the great variety
of illnesses, patients and their families are often confronted with similar types of
problems. The site targets people who know about the daily troubles of rare disease
patients – whether that is the patient himself or other people connected to patients.
These people might have thought about tricky problems, possible solutions and even
practical implementations.
To become a participating member, people do not have to possess experience on rare
conditions. The site’s intention is to bring people from diverse backgrounds together
– whether that is caregivers, health workers, physicians, nurses (i.e. core inside
innovators); family members, friends, fellow patients (i.e. peripheral inside innovators);
or researchers, engineers, product managers, civil servants (i.e. outside innovators).
The research group behind the platform organises challenges in which participants
can compete for the best ideas (see figure 5). During a challenge, which lasts for
approximately three months, participants can present unsolved problems, submit
solution proposals, and collectively work on refining ideas and concepts. At this point,
the social community features of the site enable members to create a personal profile,
connect to others, discuss ideas, and comment on others’ contributions. Proposals for
solutions on GemeinsamSelten can cover descriptions on technical aids and products,
medical and caregiving services, medical-technical services, or housekeeping and
social services.
Figure 5: At „Gemeinsam für die Seltenen” innovation contests take place
in so-called challenges
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4www.gemeinsamselten.de
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After the closing date of each challenge, a jury of experts assesses the most innovative
concepts. The multi-disciplinary jury consists of researchers and practitioners from
clinical as well as commercial organisations. The jury members evaluate each solution
proposal along a predefined set of criteria such as novelty, usefulness, feasibility,
market potential, and degree of elaboration. Not only do final winners of the contest
collect prizes, but they are also supported in innovation workshops to develop
concepts for prototypes.
GemeinsamSelten is part of an initiative from the German Federal Ministry of
Education and Research, which has defined priority projects of which one is the
‘development of local service concepts especially in the field of rare diseases’.
The term ‘Gemeinsam für die Seltenen’ can be translated as ‘jointly fighting rare
diseases’. It illustrates the point that the many are collaborating to support the few.
In summary, the platform has three distinctive features; it organises a series of
innovation contest-like challenges to find solutions for improving the quality of life of
rare disease patients; collects patient’s problems and needs in a central place; and
creates a community with people from diverse backgrounds to promote knowledge
exchange and collaborate on innovative concepts.
PatientsLikeMe
The platform PatientsLikeMe5 is a health information system that looks, at first glance,
similar to patient chat rooms and support groups. The site, which has been operating
since 2006, is specifically designed for patients to meet and discuss their ailments
with other patients. With a clear focus on patients facing life-changing and rare
illnesses, the 116,000 or so registered patients (as of October 2011), mainly from the
UK and the US, are organised in disease-based communities, such as amyotrophic
lateral sclerosis (ALS), multiple sclerosis (MS), fibromyalgia, acquired immune
deficiency syndrome (AIDS), depression and anxiety. It has been recognised by
Fast Company, a monthly magazine in the US, in its 2010 ranking of the world’s
50 most innovative companies. In an industry-specific ranking it ranked as second
most innovative in healthcare.
On PatientsLikeMe, patients provide a detailed record about their health information
and then make it public to the community. The record contains a combination of
structured and unstructured data about symptoms, severity, progress, medication and
their side effects. Health data is neatly represented using standardised metrics and
clear graphical displays. Once shared with other patients, they can enter into active
dialogue via the web platform and learn from collective knowledge and experience.
5www.patientslikeme.com
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Another outstanding characteristic of PatientsLikeMe is the philosophy of openness
within the community – in addition to their privacy policy towards non-members.
For most online users, protection of private and personal data is an imperative that
platform operators must adhere to. For patients with incurable and life-changing
diseases who are looking for ways to prolonging their life, the case might be different.
The makers of the site assume that open collaboration on a large scale with real-world
data enables change, and possibly new treatments.
Apart from patients, there is collaboration with several nonprofit groups as well as
pharmaceutical companies. It is an essential part of the business model. PatientsLikeMe
is very clear in stating that aggregated anonymous data is sold to drug, device, and
insurance companies – all with the consent of its members. For example, Novartis and
Avanir, both research-based pharmaceutical organisations, are partnering with the site
to recruit participants for clinical studies.These firms can publish online pre-screeners
on the site that help to select patients who are eligible for a clinical trial to test drugs,
for example. In the case of Novartis, it is reported that the site helped to speed up
an MS trial by several months. In brief, PatientsLikeMe offers: graphically enhanced
personal health record for rare disease patients; open sharing of personal health data
in social network; and matchmaking between patients and researchers.
Apart from
patients, there
is collaboration
with several
nonprofit
groups
as well as
pharmaceutical
companies.
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List of further examples
Name Link Type Description
HealthGrades www.healthgrades.com Appraisal system Healthcare ratings, information,
and advisory services in the US
PatientOpinion www.patientopinion.org.uk Appraisal system Feedback platform for UK
health services
RateMyHospital www.ratemyhospital.ie Appraisal system Hospital ratings by users in Ireland
Dossia www.dossia.org Electronic health record Patient managed health record
Hello Health www.hellohealth.com Electronic health record Patient managed health record
and appointment booking system
Microsoft Health Vault www.healthvault.com Electronic health record Patient managed health record
SugarStats www.sugarstats.com Electronic health record Blood sugar tracker and diabetes
management system
NHS HealthSpace www.healthspace.nhs.uk Electronic health record Online personal health organiser
integrating electronic medical
records from the NHS
Cochrane Library www.thecochranelibrary.com Information aggregation Library of systematic reviews
of primary research in human
healthcare and health policy
DocCheck www.doccheck.com Information aggregation Password service for medical
professionals and attached
expert community
EverydayHealth www.everydayhealth.com Information aggregation Information portal on everyday
health and healthcare
Healthline www.healthline.com Information aggregation Information portal on general
health and healthcare
HealthMap www.healthmap.org Information aggregation Information system visualising
global disease outbreaks
according to geography
MEDgle www.medgle.com Information aggregation Information portal on symptoms,
diagnoses, drugs, procedures
MedlinePlus.gov www.medlineplus.gov Information aggregation Information portal on general
health and healthcare by the
US National Institute of Health
MSN Health www.health.msn.com Information aggregation Information portal on general
health and healthcare
MumsNet www.mumsnet.com Information aggregation Information portal on parenting
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List of further examples (continued)
Name Link Type Description
NetDoctor www.netdoctor.co.uk Information aggregation UK-based information portal
on general health and healthcare
NHS Choices www.nhs.uk Information aggregation Information portal on general
health and healthcare from the NHS
Revolution Health www.revolutionhealth.com Information aggregation Health-related portal
and social network
VisibleBody www.visiblebody.com Information aggregation 3D human anatomy visualisation
WebMD www.webmd.com Information aggregation Largest health-related portal
and social network in the US
Who is sick www.whoissick.org Information aggregation Local sickness information
Yahoo Health www.health.yahoo.com Information aggregation Information portal on general
health and healthcare
Zygote Body www.zygotebody.com Information aggregation 3D human anatomy visualisation
PubMed www.ncbi.nlm.nih.gov/pubmed Search Database accessing references
and abstracts on life sciences
and biomedical topics
ZocDoc www.zocdoc.com Search Search for doctors and medical
appointment booking service
Cure Together www.curetogether.com Social Network Data-driven social networking
health site
Daily Strength www.dailystrength.org Social Network Social networking health site
Doctors.net.uk www.doctors.net.uk Social Network UK-based social networking site
exclusive to physicians
Gemeinsam für
die Seltenen
www.gemeinsamselten.de Social Network Innovation contests for patients
with rare diseases
Inspire www.inspire.com Social Network Social networking health site
PatientsLikeMe www.patientslikeme.com Social Network Data-driven social networking
health site
Sermo www.sermo.com Social Network US-based social networking
site exclusive to physicians
Wiki Surgery www.wikisurgery.com Wiki Surgical encyclopaedia
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conclusion
We began this report by looking at the serious challenges in healthcare and the
emerging need for innovation in this area. Put simply, the current trajectories for the
delivery of reliable and high quality healthcare at a sustainable cost cannot be supported
much further – and so there is a need for radical change across the sector.This is true
irrespective of the underlying business model and level of state involvement.
The question then is how innovation across the sector might be accelerated – and
there are valuable lessons here to take from the major changes seen elsewhere as a
result of opening up the innovation process. Innovation has always been a collaborative,
multi-player activity – but in today’s knowledge rich environment even the largest
organisations are recognising that ‘not all the smart guys work for us’. This drives
a search to engage and employ a wide range of additional players – from inside and
outside the organisation’s boundaries in multiple ways which allows the innovation
net to be cast much more widely. (We discuss some of these trends in an earlier AIM
Executive Briefing, ‘Open Collective Innovation: the power of the many over the few’).
…the current
trajectories for
the delivery
of reliable and
high quality
healthcare at
a sustainable
cost cannot
be supported
much further…
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One fruitful direction for many public and private sector organisations has been to
seek the ideas and involvement of their users – and the potential certainly exists for
doing so within healthcare. There are many examples where patients have played a
key role in developing solutions to their healthcare challenges – and there is evidence
that this process is accelerating. In this report we have tried to focus on one of the
new avenues along which such engagement might take place – the growing use of
online and interactive platforms in the healthcare sector, often termed as health 2.0.
Health 2.0 platforms seem promising for two reasons. Firstly, Web 2.0 technologies
offer a growing number of ways in which patients can acquire a voice on the internet,
and that voice can be heard by others, with the conversations moving towards shared
solution generation. Compared to the first generation of the internet, Web 2.0 offers
significant advances in user participation, openness, and network effects. We know
that community-based based innovation in online communities works in other
industries – and potentially healthcare can profit from it as well.
Secondly, patients obtain easier access to health-related information and are able to
gain a better understanding of their health status. In peer-led patient communities, this
means that patients (and their carers) can not only provide each other with knowledge
and support – they can also enable one another to comprehend the necessary medical
information and science in the context of the respective disorder. Such communities,
characterised by a high degree of interaction between users, and reciprocal exchange
of information, have been shown to be powerful engines of innovation.
As with so much of the information revolution, the technical possibilities outstrip our
capabilities to use them to full effect. But there is evidence that we are learning, not
least through powerful social networking approaches which are becoming so much
more familiar with the widespread use of Facebook, Twitter and other platforms.
Building interactive online communities and mobilising these towards meeting key
needs and dealing with shared problems is of growing relevance – and in some ways
offers one of the most concrete ways in which a ‘Big Society’ approach to social
innovation can happen. As the examples in this report show, there is considerable
potential – however, success in realising that potential will depend in part on bottom-
up community organisation (something which patients groups have already learned
to do) and partly on top-down recognition, support and user-education.
There are
many examples
where patients
have played
a key role in
developing
solutions to
their healthcare
challenges…
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